Cargando…
SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357014/ https://www.ncbi.nlm.nih.gov/pubmed/32699587 http://dx.doi.org/10.1177/2042018820942385 |
_version_ | 1783558615274094592 |
---|---|
author | La Vignera, Sandro Cannarella, Rossella Condorelli, Rosita A. Torre, Francesco Aversa, Antonio Calogero, Aldo E. |
author_facet | La Vignera, Sandro Cannarella, Rossella Condorelli, Rosita A. Torre, Francesco Aversa, Antonio Calogero, Aldo E. |
author_sort | La Vignera, Sandro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7357014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-73570142020-07-21 SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer La Vignera, Sandro Cannarella, Rossella Condorelli, Rosita A. Torre, Francesco Aversa, Antonio Calogero, Aldo E. Ther Adv Endocrinol Metab Letter to the Editor SAGE Publications 2020-07-11 /pmc/articles/PMC7357014/ /pubmed/32699587 http://dx.doi.org/10.1177/2042018820942385 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Letter to the Editor La Vignera, Sandro Cannarella, Rossella Condorelli, Rosita A. Torre, Francesco Aversa, Antonio Calogero, Aldo E. SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer |
title | SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer |
title_full | SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer |
title_fullStr | SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer |
title_full_unstemmed | SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer |
title_short | SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer |
title_sort | sars-cov-2: the endocrinological protective clinical model derived from patients with prostate cancer |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357014/ https://www.ncbi.nlm.nih.gov/pubmed/32699587 http://dx.doi.org/10.1177/2042018820942385 |
work_keys_str_mv | AT lavignerasandro sarscov2theendocrinologicalprotectiveclinicalmodelderivedfrompatientswithprostatecancer AT cannarellarossella sarscov2theendocrinologicalprotectiveclinicalmodelderivedfrompatientswithprostatecancer AT condorellirositaa sarscov2theendocrinologicalprotectiveclinicalmodelderivedfrompatientswithprostatecancer AT torrefrancesco sarscov2theendocrinologicalprotectiveclinicalmodelderivedfrompatientswithprostatecancer AT aversaantonio sarscov2theendocrinologicalprotectiveclinicalmodelderivedfrompatientswithprostatecancer AT calogeroaldoe sarscov2theendocrinologicalprotectiveclinicalmodelderivedfrompatientswithprostatecancer |